General

@ref: 64488

BacDive-ID: 157916

DSM-Number: 101993

keywords: Bacteria, mesophilic, antibiotic resistance

description: Acinetobacter baumannii DSM 101993 is a mesophilic bacterium that has multiple antibiotic resistances.

NCBI tax id

• NCBI tax id: 470
• Matching level: species

strain history

• @ref: 64488
• history: <- A. F. de Vos and T. van der Poll, Amsterdam UMC

doi: 10.13145/bacdive157916.20250331.9.3

Name and taxonomic classification

LPSN

• @ref: 20215
• description: domain/bacteria
• keyword: phylum/pseudomonadota
• domain: Bacteria
• phylum: Pseudomonadota
• class: Gammaproteobacteria
• order: Pseudomonadales
• family: Moraxellaceae
• genus: Acinetobacter
• species: Acinetobacter baumannii
• full scientific name: Acinetobacter baumannii Bouvet and Grimont 1986

@ref: 64488

domain: Bacteria

phylum: Proteobacteria

class: Gammaproteobacteria

order: Pseudomonadales

family: Moraxellaceae

genus: Acinetobacter

species: Acinetobacter baumannii

full scientific name: Acinetobacter baumannii Bouvet and Grimont 1986

type strain: no

Culture and growth conditions

culture medium

• @ref: 64488
• name: LB (Luria-Bertani) MEDIUM (DSMZ Medium 381)
• growth: yes
• link: https://mediadive.dsmz.de/medium/381
• composition: Name: LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) Composition: Agar 20.0 g/l NaCl 10.0 g/l Tryptone 10.0 g/l Yeast extract 5.0 g/l Distilled water

culture temp

• @ref: 64488
• growth: positive
• type: growth
• temperature: 37

Physiology and metabolism

antibiogram

• @ref: 64488
• medium: Mueller-Hinton Agar
• incubation temperature: 30
• oxygen condition: aerob
• Penicillin G: 0
• oxacillin: 0
• ampicillin: 0
• ticarcillin: 0
• mezlocillin: 0
• cefalotin: 0
• cefazolin: 0
• cefotaxime: 0
• aztreonam: 0
• imipenem: 34-36
• tetracycline: 0
• chloramphenicol: 0
• gentamycin: 6
• amikacin: 20
• vancomycin: 0
• erythromycin: 10
• lincomycin: 0
• ofloxacin: 0
• norfloxacin: 0
• colistin: 14-16
• pipemidic acid: 0
• nitrofurantoin: 0
• bacitracin: 0
• polymyxin b: 16-18
• kanamycin: 0
• neomycin: 8-10
• doxycycline: 12
• ceftriaxone: 6
• clindamycin: 0
• fosfomycin: 8
• moxifloxacin: 6-8
• linezolid: 0
• nystatin: 0
• quinupristin/dalfopristin: 0
• teicoplanin: 0
• piperacillin/tazobactam: 12

Safety information

risk assessment

• @ref: 64488
• biosafety level: 2
• biosafety level comment: Risk group (German classification)

External links

@ref: 64488

culture collection no.: DSM 101993, RUH 2037

straininfo link

• @ref: 110768
• straininfo: 405736

phages

literature

• topic: Pathogenicity
• Pubmed-ID: 35062236
• title: Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection.
• authors: Wienhold SM, Brack MC, Nouailles G, Krishnamoorthy G, Korf IHE, Seitz C, Wienecke S, Dietert K, Gurtner C, Kershaw O, Gruber AD, Ross A, Ziehr H, Rohde M, Neudecker J, Lienau J, Suttorp N, Hippenstiel S, Hocke AC, Rohde C, Witzenrath M
• journal: Viruses
• DOI: 10.3390/v14010033
• year: 2021
• mesh: Acinetobacter Infections/immunology/microbiology/pathology/*therapy, *Acinetobacter baumannii/drug effects/virology, Animals, Anti-Bacterial Agents/pharmacology, Cytokines/metabolism, Drug Resistance, Multiple, Bacterial, Female, Humans, Lung/immunology/microbiology/pathology, Mice, Mice, Inbred C57BL, Myoviridae/*physiology, *Phage Therapy/adverse effects, Pneumonia, Bacterial/immunology/microbiology/pathology/*therapy
• topic2: Metabolism

Reference